Atlas Trials

Non-valvular Atrial Fibrillation (NVAF)

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-valvular Atrial Fibrillation (NVAF)

RecordFirmDate
A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin (NCT05022758)Bayer2021-10-06
A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan (NCT05027061)Bristol-Myers Squibb2021-04-02
A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation (NCT05232643)Bristol-Myers Squibb2020-07-09
Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function (NCT04356989)Bayer2020-05-13
Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation (NCT03746301)Bayer2018-12-03
Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) (NCT03234114)The First Affiliated Hospital with Nanjing Medical University2018-02-03
AMPLATZERâ„¢ Cardiac Plug Observational Post-Approval Study (NCT02954237)Abbott Medical Devices2016-11-14
Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry (NCT02663076)GWT-TUD GmbH2016-04-01
Early Post-marketing Study of Eliquis (Apixaban) (NCT02153424)Bristol-Myers Squibb2014-04-01

Track Non-valvular Atrial Fibrillation (NVAF) automatically

Every clearance here is in the API, with alerts when new ones post.